Disability in older people with diabetes: Issues for the clinician

British Journal of Diabetes and Vascular Disease

Volumn 12, Issue 3, 2012, Pages 135-140

  Bourdel Marchasson, Isabelle ^a,b,c   Dugaret, Elodie ^a,b   Regueme, Sophie ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CNRS University Bordeaux Segalen   (France)

Author keywords

cognitive disorders; disability; frailty; health education

Indexed keywords

CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

ARTICLE; CAREGIVER; COGNITION; COGNITIVE DEFECT; CREATININE CLEARANCE; DELIRIUM; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISABILITY; DISEASE COURSE; EDUCATION PROGRAM; FALL RISK ASSESSMENT; FUNCTIONAL STATUS; GERIATRIC CARE; HEALTH CARE ORGANIZATION; HUMAN; INSULIN RESISTANCE; KIDNEY FUNCTION; MINI MENTAL STATE EXAMINATION; NUTRITIONAL ASSESSMENT; PATIENT ASSESSMENT; PATIENT EDUCATION; QUALITY OF LIFE; RISK FACTOR; SYSTOLIC HYPERTENSION; VISUAL ANALOG SCALE;

EID: 84863001442     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651412448404     Document Type: Article

References (55)

1. Bourdel-Marchasson I, Helmer C, Fagot-Campagna A, et al. Disability and quality of life in elderly people with diabetes. Diabetes Metab. 2007 ; 33: S66-74
2. Fagot-Campagna A, Bourdel-Marchasson I, Simon D. Burden of diabetes in an aging population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab. 2005 ; 31 (spec no 2). 5S35-32
3. Pornet C, Bourdel-Marchasson I, Lecomte P, et al. Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 Entred Surveys). Diabetes Metab. 2011 ; 37: 152-61
4. Bourdel Marchasson I. Sinclair AJ, ed. Chippenham: Wiley-Blackwell ; 2009: 453-9.
5. Bourdel-Marchasson I, Berrut G. Caring for the elderly diabetic patient with respect to concepts of successful aging and frailty. Diabetes Metab. 2005 ; 31 (spec no 2). 5S13-9 (Pubitemid 43106439)
6. Jayasinghe UW, Proudfoot J, Barton CA, et al. Quality of life of Australian chronically-ill adults: patient and practice characteristics matter. Health Qual Life Outcomes. 2009 ; 7: 50
7. Graham JE, Stoebner-May DG, Ostir GV, et al. Health related quality of life in older Mexican Americans with diabetes: a cross-sectional study. Health Qual Life Outcomes. 2007 ; 5: 39
8. Sinclair AJ, Conroy SP, Bayer AJ. Impact of diabetes on physical function in older people. Diabetes Care. 2008 ; 31: 233-5 (Pubitemid 351222517)
9. Lifford KL, Curhan GC, Hu FB, Barbieri RL, Grodstein F. Type 2 diabetes mellitus and risk of developing urinary incontinence. J Am Geriatr Soc. 2005 ; 53: 1851-7 (Pubitemid 41826060)
10. Ko SU, Stenholm S, Chia CW, Simonsick EM, Ferrucci L. Gait pattern alterations in older adults associated with type 2 diabetes in the absence of peripheral neuropathy: results from the Baltimore Longitudinal Study of Aging. Gait Posture. 2011 ; 34: 548-52
11. Schwartz AV, Hillier TA, Sellmeyer DE, et al. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care. 2002 ;: 1749-54 (Pubitemid 41071081)
12. Rosano C, Longstreth WT, Boudreau R, Taylor CA, et al. High blood pressure accelerates gait slowing in well-functioning older adults over 18-years of follow-up. J Am Geriatr Soc. 2011 ; 59: 390-7
13. Bruce DG, Davis WA, Davis TM. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005 ; 28: 2441-7 (Pubitemid 41384291)
14. Rantanen T, Masaki K, Foley D, et al. Grip strength changes over 27 years in Japanese-American men. J Appl Physiol. 1998 ; 85: 2047-53 (Pubitemid 28558058)
15. De Rekeneire N, Resnick HE, Schwartz AV, et al. Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care. 2003 ; 26: 3257-63 (Pubitemid 37466884)
16. Park SW, Goodpaster BH, Strotmeyer ES, et al. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes. 2006 ; 55: 1813-18 (Pubitemid 44324137)
17. van Sloten TT, Savelberg HH, Duimel-Peeters IG, et al. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations. Diabetes Res Clin Pract. 2010 ; 91: 32-9
18. Bourdel-Marchasson I, Lapre E, Laksir H, Puget E. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab. 2010 ; 36: 173-81
19. Bourdel-Marchasson I, Mouries A, Helmer C. Hyperglycaemia, microangiopathy, diabetes and dementia risk. Diabetes Metab. 2010 ; 36: S112-18
20. Raffaitin C, Gin H, Empana JP, et al. Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care. 2009 ; 32: 169-74
21. Firbank MJ, Wiseman RM, Burton EJ, et al. Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure. J Neurol. 2007 ; 254: 713-21 (Pubitemid 47012443)
22. Dufouil C, de Kersaint-Gilly A, Besancon V, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology. 2001 ; 56: 921-6 (Pubitemid 32290809)
23. de Bresser J, Reijmer YD, van den Berg E, et al. Microvascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord. 2010 ; 30: 381-6
24. Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 2002 ; 51: 1157-65 (Pubitemid 34438363)
25. Brundel M, van den Heuvel M, de Bresser J, et al. Cerebral cortical thickness in patients with type 2 diabetes. J Neurol Sci. 2010 ; 299: 126-30
26. van Elderen SG, de Roos A, de Craen AJ, et al. Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up. Neurology. 2010 ; 75: 997-1002
27. Hayashi K, Kurioka S, Yamaguchi T, et al. Association of cognitive dysfunction with hippocampal atrophy in elderly Japanese people with type 2 diabetes. Diabetes Res Clin Pract. 2011 ; 94: 180-5
28. Debette S, Seshadri S, Beiser A, et al. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011 ; 77: 461-8
29. Bourdel-Marchasson I, Dubroca B, Manciet G, et al. Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey. J Am Geriatr Soc. 1997 ; 45: 295-301 (Pubitemid 27114301)
30. Ajilore O, Narr K, Rosenthal J, et al. Regional cortical gray matter thickness differences associated with type 2 diabetes and major depression. Psychiatry Res. 2010 ; 184: 63-70
31. Stewart R, Prince M, Mann A. Vascular risk factors and Alzheimer's disease. Aust N Z J Psychiatry. 1999 ; 33: 809-13 (Pubitemid 30015845)
32. Gao L, Matthews FE, Sargeant LA, Brayne C. An investigation of the population impact of variation in HbA1C levels in older people in England and Wales: from a population based multi-centre longitudinal study. BMC Public Health. 2008 ; 8: 54
33. Xu WL, von Strauss E, Qiu CX, et al. Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study. Diabetologia. 2009 ; 52: 1031-9
34. van den Berg E, de Craen AJ, Biessels GJ, et al. The impact of diabetes mellitus on cognitive decline in the oldest of the old: a prospective population-based study. Diabetologia. 2006 ; 49: 2015-23 (Pubitemid 44168467)
35. Gray SL, Boudreau RM, Newman AB, et al. Angiotensin-Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community-Dwelling Older Adults: The Health, Aging and Body Composition Study. J Am Geriatr Soc. 2011 ; 59: 2226-32
36. LaCroix AZ, Gray SL, Aragaki A, et al. Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study. J Gerontol A Biol Sci Med Sci. 2008 ; 63: 369-75 (Pubitemid 351738418)
37. Haerer W, Delbaere K, Bartlett H, et al. Relationships between HMG-CoA reductase inhibitors (Statin) use and strength, balance and falls in older pople. Intern Med J. 2011
38. Dobkin BH. Underappreciated statin-induced myopathic weakness causes disability. Neurorehabil Neural Repair. 2005 ; 19: 259-63 (Pubitemid 41216302)
39. Schwartz AV, Vittinghoff E, Sellmeyer DE, et al. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008 ; 31: 391-6
40. Wang CP, Hazuda HP. Better glycemic control is associated with maintenance of lower-extremity function over time in Mexican American and European American older adults with diabetes. Diabetes Care. 2011 ; 34: 268-73
41. Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 ; 358: 2560-72 (Pubitemid 351831357)
42. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007 ; 370: 829-40 (Pubitemid 47362321)
43. Trompet S, van Vliet P, de Craen AJ, et al. Pravastatin and cognitive function in the elderly. Results of the PROSPER study. J Neurol. 2009 ; 257: 85-90
44. Von Korff M, Katon WJ, Lin EH, et al. Functional outcomes of multi-condition collaborative care and successful ageing: results of randomised trial. BMJ. 2011 ; 343: d6612
45. Kamiyama T, Muratani H, Kimura Y, et al. Divergent effects of beta-blocker therapy on self-estimated and objectively scored activities of daily living. Hypertens Res. 1999 ; 22: 85-93 (Pubitemid 29371681)
46. Bourdel Marchasson I, Doucet J, Bauduceau B, et al. Key priorities in managing glucose control in older people with diabetes. J Nutr Health Aging. 2009 ; 13: 685-91
47. Sinclair A, Paolisso G, Castro M, et al. European Diabetes Working Party for Older People 2011; Clinical Guidelines for Type 2 Diabetes Mellitus (EDWPOP): A Report for the European Diabetes Working Party for Older People (EDWPOP) Revision Group on Clinical Practice Guidelines for Type 2 Diabetes Mellitus. Diabetes Metab. 2011 ; 37 (spec no 3). S27-38
48. Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994 ; 49: M85-94
49. Bandinelli S, Lauretani F, Boscherini V, et al. A randomized, controlled trial of disability prevention in frail older patients screened in primary care: the FRASI study. Aging Clin Exp Res. 2006 ; 18: 359-66 (Pubitemid 46138520)
50. Sinclair AJ, Girling AJ, Bayer AJ. Cognitive dysfunction in older subjects with diabetes mellitus: impact on diabetes self-management and use of care services. Diabetes Res Clin Pract. 2000 ; 50: 203-12
51. Zeyfang A, Berndt S, Aurnhammer G, et al. A Short Easy Test Can Detect Ability for Autonomous Insulin Injection by the Elderly With Diabetes Mellitus. J Am Med Dir Assoc. 2012 ; 13: 81.e15-8
52. Braun AK, Kubiak T, Kuntsche J, et al. SGS: a structured treatment and teaching programme for older patients with diabetes mellitus - A prospective randomised controlled multi-centre trial. Age Ageing. 2009 ; 38: 390-6
53. Tessier DM, Lassmann-Vague VJ. Diabetes and education in the elderly. Diabetes Metab. 2007 ; 33: S75-8
54. Courtney M, Edwards H, Chang A, Parker A, et al. Fewer emergency readmissions and better quality of life for older adults at risk of hospital readmission: a randomized controlled trial to determine the effectiveness of a 24-week exercise and telephone follow-up program. J Am Geriatr Soc. 2009 ; 57: 395-402
55. Wilson C, Curtis J, Lipke S, et al. Nurse case manager effectiveness and case load in a large clinical practice: implications for workforce development. Diabet Med. 2005 ; 22: 1116-20 (Pubitemid 41026014)